Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021

SELL
$37.26 - $67.74 $968,760 - $1.76 Million
-26,000 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$45.01 - $65.47 $472,605 - $687,435
10,500 Added 67.74%
26,000 $1.54 Million
Q2 2020

Aug 06, 2020

SELL
$24.95 - $48.38 $421,655 - $817,622
-16,900 Reduced 52.16%
15,500 $750,000
Q1 2020

May 11, 2020

BUY
$16.96 - $34.16 $242,528 - $488,487
14,300 Added 79.01%
32,400 $900,000
Q4 2019

Feb 05, 2020

BUY
$24.56 - $32.8 $444,536 - $593,680
18,100 New
18,100 $539,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.